Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Hari R Mallidi, M.D.

Concepts

This page shows the publications Hari Mallidi has written about Time Factors.
Connection Strength

0.238
  1. Posttransplant Lymphoproliferative Disorders in Epstein-Barr Virus Donor Positive/Recipient Negative Lung Transplant Recipients. Ann Thorac Surg. 2018 Feb; 105(2):441-447.
    View in: PubMed
    Score: 0.037
  2. Continuous-flow ventricular assist device exchange is safe and effective in prolonging support time in patients with end-stage heart failure. J Thorac Cardiovasc Surg. 2015 Jan; 149(1):267-75, 278.e1.
    View in: PubMed
    Score: 0.030
  3. Transplantation for idiopathic pulmonary arterial hypertension: improvement in the lung allocation score era. Circulation. 2013 Jun 25; 127(25):2503-13.
    View in: PubMed
    Score: 0.027
  4. Heart transplant graft survival is improved after a reduction in panel reactive antibody activity. J Thorac Cardiovasc Surg. 2013 Feb; 145(2):555-64; discussion 564-5.
    View in: PubMed
    Score: 0.026
  5. Ventricular assist devices: history, patient selection, and timing of therapy. J Cardiovasc Transl Res. 2009 Jun; 2(2):159-67.
    View in: PubMed
    Score: 0.020
  6. The short-term and long-term effects of warm or tepid cardioplegia. J Thorac Cardiovasc Surg. 2003 Mar; 125(3):711-20.
    View in: PubMed
    Score: 0.013
  7. The impact of statin therapy on neurological events following left ventricular assist system implantation in advanced heart failure. J Heart Lung Transplant. 2020 06; 39(6):582-592.
    View in: PubMed
    Score: 0.011
  8. Comparison of heart transplant outcomes between recipients with pulsatile- vs continuous-flow LVAD. J Card Surg. 2019 Oct; 34(10):1062-1068.
    View in: PubMed
    Score: 0.011
  9. Nonidentical Continuous-Flow Devices For Biventricular Support. Tex Heart Inst J. 2017 Apr; 44(2):141-143.
    View in: PubMed
    Score: 0.009
  10. Predictors and outcomes of unplanned early rehospitalization in the first year following lung transplantation. Clin Transplant. 2016 09; 30(9):1053-8.
    View in: PubMed
    Score: 0.008
  11. Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study. Tex Heart Inst J. 2015 Oct; 42(5):419-29.
    View in: PubMed
    Score: 0.008
  12. Aspergillus Mediastinitis after Orthotopic Heart Transplantation: A Case Report. Tex Heart Inst J. 2015 Oct; 42(5):468-70.
    View in: PubMed
    Score: 0.008
  13. Surgical approach to continuous-flow left ventricular assist device explantation: A comparison of outcomes. J Thorac Cardiovasc Surg. 2016 Jan; 151(1):192-8.
    View in: PubMed
    Score: 0.008
  14. Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2015 Jun; 34(6):766-72.
    View in: PubMed
    Score: 0.007
  15. Association between cell-derived microparticles and adverse events in patients with nonpulsatile left ventricular assist devices. J Heart Lung Transplant. 2014 May; 33(5):470-7.
    View in: PubMed
    Score: 0.007
  16. Early outcomes of deliberate nonoperative management for blunt thoracic aortic injury in trauma. J Thorac Cardiovasc Surg. 2010 Sep; 140(3):598-605.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.